Method and formulation for treating respiratory diseases
AssigneeEnterobiome Inc.
InventorsJae-Gu SEO, Joo-Hyun SHIN, Do-Kyung LEE
Life of this patent
Estimating the term…
Abstract
A novel Akkermansia muciniphila strain is disclosed. The novel strain has effects of preventing or treating inflammatory or metabolic diseases. A composition containing the novel strain or a culture thereof are also disclosed. The novel strain, cultures thereof, or compositions containing the novel strain and/or cultures thereof are suitable to use in methods of preventing or treating inflammatory or metabolic diseases.
Claims16
A method for preventing or treating a respiratory disease of a subject in need thereof, or at least one symptom associated with the respiratory disease of the subject, the method comprising administering to the subject Akkermansia muciniphilia strains (accession number KCTC 13761BP), a culture thereof, or a dried product of the culture, wherein the respiratory disease is selected from the group consisting of asthma, allergic rhinitis, chronic rhinosinusitis, and chronic obstructive pulmonary disease.
A formulation for preventing or improving a respiratory disease of a subject in need thereof, or at least one symptom associated with the respiratory disease of the subject, the formulation comprising Akkermansia muciniphilia EB-AMDK19 strains having the accession number KCTC 13761BP and a carrier and/or an excipient.
Dependencies are inferred from the claim text.